INVA FY 2024 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$359M+15.5% YoY

Gross Profit

$322M89.8% margin

Operating Income

$167M46.5% margin

Net Income

$23M6.5% margin

EPS (Diluted)

$0.36

Cash Flow

Operating Cash Flow

$189M

Free Cash Flow

$188M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$610M

Stockholders' Equity

$691M

Cash & Equivalents

$305M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$359M	$310M	+15.5%
Gross Profit	$322M	$268M	+20.3%
Operating Income	$167M	$114M	+46.5%
Net Income	$23M	$180M	-87.0%